Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease
Status:
Withdrawn
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this observational study is to investigate the
clinical safety profile and effectiveness while using SC NovoRapid™ (insulin aspart) in
patients with coexisting diabetes and kidney disease under normal clinical practice
conditions in India.